Published in Eur J Surg Oncol on November 01, 2003
Factors predicting the axillary lymph node metastasis in breast cancer: is axillary node clearance indicated in every breast cancer patient?: factors predicting the axillary lymphnode metastases in breast cancer. Indian J Surg (2011) 0.75
Factors Influencing Non-sentinel Node Involvement in Sentinel Node Positive Patients and Validation of MSKCC Nomogram in Indian Breast Cancer Population. Indian J Surg Oncol (2015) 0.75
Concordance between telepathologic diagnosis and conventional histopathologic diagnosis: a multiobserver store-and-forward study on 20 skin specimens. Arch Dermatol (2002) 2.07
Overexpression of the RON gene in human breast carcinoma. Oncogene (1998) 1.73
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy. Ann Oncol (2005) 1.72
Interobserver variability on the histopathologic diagnosis of cutaneous melanoma and other pigmented skin lesions. J Clin Oncol (1996) 1.67
The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer. Br J Cancer (1996) 1.51
Granular cell ameloblastoma: a case report with histochemical findings. Eur J Cancer B Oral Oncol (1996) 1.49
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer. Updated results of the Italian tamoxifen anastrozole (ITA) trial. Ann Oncol (2006) 1.47
Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study. Ann Oncol (1994) 1.43
Silencing the MET oncogene leads to regression of experimental tumors and metastases. Oncogene (2007) 1.42
Role of transvaginal sonography in the detection of endometriomata. J Clin Ultrasound (1995) 1.40
Morphometric analysis of AgNORs in uveal malignant melanoma. Anal Quant Cytol Histol (1998) 1.39
Prostate-specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res (1995) 1.38
A primary, lateral-cervical medullary thyroid carcinoma: a case report. J Clin Endocrinol Metab (1996) 1.38
FGFRI and PLAT genes and DNA amplification at 8p12 in breast and ovarian cancers. Genes Chromosomes Cancer (1993) 1.37
Overexpression of the Met/HGF receptor in ovarian cancer. Int J Cancer (1994) 1.36
Transcatheter closure of persistent ductus arteriosus with the Amplatzer duct occluder in very young symptomatic children. Heart (2004) 1.31
A glossary for reporting complications of treatment in gynecological cancers. Radiother Oncol (1993) 1.30
Clinically equivocal melanocytic skin lesions with features of regression: a dermoscopic-pathological study. Br J Dermatol (2004) 1.27
Prostate specific antigen in breast cancer, benign breast disease and normal breast tissue. Breast Cancer Res Treat (1996) 1.27
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors. J Endocrinol Invest (2008) 1.14
Accelerated bone mass senescence after hematopoietic stem cell transplantation. Transl Med UniSa (2013) 1.13
Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res (2003) 1.13
Conservative surgery with and without radiotherapy in elderly patients with early-stage breast cancer: a prospective randomised multicentre trial. Breast (2009) 1.11
Expression of cell cycle and apoptosis-related proteins in sporadic odontogenic keratocysts and odontogenic keratocysts associated with the nevoid basal cell carcinoma syndrome. J Dent Res (1999) 1.08
Prognostic value of a novel circulating serum 90K antigen in breast cancer. Br J Cancer (1994) 1.08
An anomalous positron abundance in cosmic rays with energies 1.5-100 GeV. Nature (2009) 1.07
Odontogenic myxoma: report of a case with peculiar features. J Oral Maxillofac Surg (1991) 1.06
Tricholemmal carcinoma: a study of seven cases. J Cutan Pathol (1992) 1.06
Survivin expression in oral squamous cell carcinoma. Br J Cancer (2003) 1.06
Diagnostic accuracy of the serum profile of gastric mucosa in relation to histological and morphometric diagnosis of atrophy. Aliment Pharmacol Ther (2005) 1.05
Is serum troponin T a useful marker of myocardial damage in newborn infants with perinatal asphyxia? Acta Paediatr (2007) 1.05
Cardiac adverse effects of early dexamethasone treatment in preterm infants: a randomized clinical trial. J Clin Pharmacol (2001) 1.05
Primary monotypic epithelioid angiomyolipoma of bone. Histopathology (2002) 1.04
Early detection of breast cancer recurrences through periodic follow-up--is it useless? Tumori (1985) 1.04
Creatine kinase BB isoenzyme levels in tumour cytosols and survival of breast cancer patients. Br J Cancer (1996) 1.03
Serum total and free prostate-specific antigen for breast cancer diagnosis in women. Clin Cancer Res (2000) 1.03
Mutant p53 protein overexpression is associated with poor outcome in patients with well or moderately differentiated ovarian carcinoma. Cancer (1995) 1.02
Role of MRI (magnetic resonance imaging) versus conventional imaging for breast cancer presurgical staging in young women or with dense breast. Eur J Surg Oncol (2011) 1.01
Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1. Oncogene (1997) 1.01
Objective and self-reported cognitive dysfunction in breast cancer women treated with chemotherapy: a prospective study. Eur J Cancer Care (Engl) (2011) 1.00
Malignant struma ovarii: a case report of laparoscopic management. Gynecol Oncol (2003) 1.00
A case of mesonephric adenocarcinoma of the vagina with a 1-year follow-up. Int J Gynecol Cancer (2007) 1.00
Primary Ewing's sarcoma of the maxilla, a rare and curable localization: report of two new cases, successfully treated by radiotherapy and systemic chemotherapy. Cancer Lett (1996) 0.98
Self-assembly nanoparticles for the delivery of bisphosphonates into tumors. Int J Pharm (2010) 0.97
Facial granulomatous diseases: a study of four cases tested for the presence of Mycobacterium tuberculosis DNA using nested polymerase chain reaction. Am J Dermatopathol (2001) 0.96
Comparison of CT- or ultrasound-guided drainage with concomitant intravenous antibiotics vs. intravenous antibiotics alone in the management of tubo-ovarian abscesses. Ultrasound Obstet Gynecol (2007) 0.96
Measurement of a breast cancer associated antigen detected by monoclonal antibody SP-2 in sera of cancer patients. Breast Cancer Res Treat (1988) 0.95
Tumor infiltrating lymphocytes in uveal melanoma: a link with clinical behavior? Int J Immunopathol Pharmacol (2006) 0.95
Hemosiderotic dermatofibroma: report of one case. Dermatology (2007) 0.95
Non-hormonal treatment of hot flushes in breast cancer survivors: gabapentin vs. vitamin E. Climacteric (2009) 0.94
Clinical outcome of adjuvant endocrine treatment according to PR and HER-2 status in early breast cancer. Ann Oncol (2006) 0.94
c-erbB-2 and ras expression levels in breast cancer are correlated and show a co-operative association with unfavorable clinical outcome. Int J Cancer (1991) 0.93
Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol (2001) 0.93
TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients. Anticancer Res (1996) 0.93
Dermatoscopic pitfalls in differentiating pigmented Spitz naevi from cutaneous melanomas. Br J Dermatol (1999) 0.92
New measurement of the antiproton-to-proton flux ratio up to 100 GeV in the cosmic radiation. Phys Rev Lett (2009) 0.92
OPN/CD44v6 overexpression in laryngeal dysplasia and correlation with clinical outcome. Br J Cancer (2007) 0.91
Nanotech revolution for the anti-cancer drug delivery through blood-brain barrier. Curr Cancer Drug Targets (2012) 0.91
Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC). Eur J Surg Oncol (2013) 0.91
Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol (1993) 0.91
Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease. Prostate Cancer Prostatic Dis (2005) 0.91
Scatter factor receptor (c-Met) as possible prognostic factor in patients with oral squamous cell carcinoma. Anticancer Res (2004) 0.91
PLGA microspheres encapsulating siRNA anti-TNFalpha: efficient RNAi-mediated treatment of arthritic joints. Eur J Pharm Biopharm (2012) 0.91
Angiomatoid malignant fibrous histiocytoma: cytologic, immunohistochemical, ultrastructural, and flow cytometric study of 20 cases. Mod Pathol (1990) 0.90
Tamoxifen and endometrial cancer. Ann N Y Acad Sci (1994) 0.90
Variations of proline-rich kinase Pyk2 expression correlate with prostate cancer progression. Lab Invest (2001) 0.90
Fine-needle aspiration biopsies of breast masses. A critical analysis of 1956 cases in 8 years (1976-1984). Cancer (1988) 0.89
Prolactin secretion after beer. Lancet (1981) 0.89
Chromatin assembly factor-1 (CAF-1)-mediated regulation of cell proliferation and DNA repair: a link with the biological behaviour of squamous cell carcinoma of the tongue? Histopathology (2007) 0.89
Laparoscopic identification of pelvic nerves in patients with deep infiltrating endometriosis. Surg Endosc (2004) 0.88
Beta- and gamma-catenin expression in oral squamous cell carcinomas. Anticancer Res (2000) 0.88
Behaviour of ovarian tumors of low malignant potential treated with conservative surgery. Eur J Surg Oncol (2008) 0.88
Estrogen receptor beta expression in human prostate tissue. Mol Cell Endocrinol (2001) 0.88
Immunoenzymatically determined pepsinogen C concentration in breast tumor cytosols: an independent favorable prognostic factor in node-positive patients. Clin Cancer Res (1999) 0.88
The prognostic significance of tumor angiogenesis in nonaggressive and aggressive basal cell carcinoma of the human skin. Hum Pathol (1996) 0.87
HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma. Histol Histopathol (2004) 0.87
Loss of oestrogen receptor beta, high PCNA and p53 expression and aneuploidy as markers of worse prognosis in ovarian granulosa cell tumours. Histopathology (2003) 0.87
Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity. Int J Biol Markers (2001) 0.87
Thymoma: a clinico-pathologic study based on newly developed morphologic criteria. Tumori (1988) 0.87
Left ventricle dimensions in preterm infants during the first month of life. Eur J Pediatr (2001) 0.87
Acute cholestasis: atypical onset of Kawasaki disease. Dig Liver Dis (2007) 0.86
Epithelioid hemangioendothelioma of the larynx. Tumori (2000) 0.86
Chemoresistance in breast tumors. Eur J Gynaecol Oncol (1991) 0.86
Sinonasal lymphoma presenting as a lethal midline granuloma: case report. J Oral Maxillofac Surg (1998) 0.86
Microstructural disorders of tunica albuginea in patients affected by Peyronie's disease with or without erection dysfunction. J Urol (1993) 0.86
Ectopic production of prostate specific antigen by a breast tumor metastatic to the ovary. J Clin Lab Anal (1994) 0.86
Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients. Int J Cancer (1998) 0.86